Other prominent pathways included lipid metabolism and atherosclerosis metabolism, NF‒κB signaling, TNF signaling, and IL‒17 signaling, which are closely associated with chronic inflammation and immune dysregulation. This evidence concerns the gene NFKB1 and atherosclerosis.